FDA Amendments Act Of 2007 By Any Other Name Would Be Preferred
This article was originally published in The Tan Sheet
Executive Summary
More than two months after the Food and Drug Administration Amendments Act of 2007 was signed into law, the drug industry remains vexed about one very important issue - what to call it
You may also be interested in...
Pre-emption Limits Survive Congress, But Will Face Supreme Court
The FDA reauthorization law signed by President Bush Sept. 27 includes provisions intended to sustain limits on federal pre-emption, but the concept is challenged in several ongoing cases that could reach the Supreme Court in coming sessions
Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.
Track-And-Trace: With Deadline a Year Away, Some Lessons from Early Adopters
EMD Serono has been tracking Serostim packages since 2002; J&J is using Prezista 600 mg as a trial run for serialization.